This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DeCaterina, R. Articles by Weksler, B. Search for Related Content PubMed PubMed Citation Articles by DeCaterina, R. Articles by Weksler, B.

Circulation, Vol 82, 428-438, Copyright © 1990 by American Heart Association

ARTICLES

Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery

R DeCaterina, D Giannessi, A Mazzone, W Bernini, G Lazzerini, S Maffei, M Cerri, L Salvatore and B Weksler
Department of Cardiovascular Surgery, Spedali Riuniti di Santa Chiara, Pisa, Italy.

Interest in the antithrombotic potential of diets enriched with fish oil-derived polyunsaturated fatty acids (omega-3 PUFAs) prompted us to examine how these fatty acids, when taken preoperatively, affect hemostasis, plasma lipid levels, and production of prostacyclin (PGI2) by vascular tissues in atherosclerotic patients undergoing coronary artery bypass graft surgery. Fifteen patients with angiographically proven coronary artery disease received 3 g/day eicosapentaenoic acid and 1.3 g/day docosahexaenoic acid as capsules of purified fish oil for 28 days before surgery. Platelet aggregation induced by low concentrations of ADP, collagen, and epinephrine decreased (p less than 0.05) and serum thromboxane B2 decreased 36% (p less than 0.01) from baseline values. Bleeding times increased 40% (p less than 0.01) from baseline. Serum triglycerides decreased 50% (p less than 0.05) without a change in total serum cholesterol. Spontaneous production of PGI2 measured as 6-ketoprostaglandin F1 alpha (6-keto-PGF1 alpha), its stable hydrolytic product, by saphenous vein and aortic and atrial tissues obtained at surgery was greater in tissues from patients receiving omega-3 PUFA supplements than in tissues from matched controls (13.8 +/- 2.2 versus 8.6, 21.0 +/- 3.1 versus 11.5 +/- 2.1, and 166 +/- 13 versus 102 +/- 15 ng/g, respectively, all p less than 0.05). Arachidonate-stimulated production of PGI2, as indicated by increased levels of 6-keto-PGF1 alpha, was increased. Despite changes in platelet function, bleeding time, and vascular PGI2, the perioperative blood loss was not increased in subjects receiving fish oil supplements. Thus, omega-3 PUFAs at moderate dosages may exert antithrombotic effects by increasing prostacyclin production by vessel walls as well as by direct inhibition of platelet activity.

This article has been cited by other articles:

				C. E. Lok, M. Allon, S. Donnelly, M. Dorval, B. Hemmelgarn, L. Moist, M. J. Oliver, M. Tonelli, and K. Stanley Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study Clinical Trials, August 1, 2007; 4(4): 357 - 367. [Abstract] [PDF]

				G. Renda, R. Di Pillo, A. D'Alleva, A. Sciartilli, M. Zimarino, E. De Candia, R. Landolfi, G. Di Giammarco, A. Calafiore, and R. De Caterina Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery Haematologica, March 1, 2007; 92(3): 366 - 373. [Abstract] [Full Text] [PDF]

				M. Massaro, A. Habib, L. Lubrano, S. D. Turco, G. Lazzerini, T. Bourcier, B. B. Weksler, and R. De Caterina The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC{varepsilon} inhibition PNAS, October 10, 2006; 103(41): 15184 - 15189. [Abstract] [Full Text] [PDF]

				S. Aiko, Y. Yoshizumi, S. Tsuwano, M. Shimanouchi, Y. Sugiura, and T. Maehara The Effects of Immediate Enteral Feeding with a Formula Containing High Levels of {omega}-3 Fatty Acids in Patients After Surgery for Esophageal Cancer JPEN J Parenter Enteral Nutr, May 1, 2005; 29(3): 141 - 147. [Abstract] [Full Text] [PDF]

				K. Vanschoonbeek, M. P. M. de Maat, and J. W. M. Heemskerk Fish Oil Consumption and Reduction of Arterial Disease J. Nutr., March 1, 2003; 133(3): 657 - 660. [Abstract] [Full Text] [PDF]

				M. Y Abeywardena and R. J Head Longchain n-3 polyunsaturated fatty acids and blood vessel function Cardiovasc Res, December 1, 2001; 52(3): 361 - 371. [Abstract] [Full Text] [PDF]

				A.P. Simopoulos Evolutionary aspects of diet, essential fatty acids and cardiovascular disease Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D8 - D21. [Abstract] [PDF]

				R. De Caterina and G. Basta n-3 Fatty acids and the inflammatory response -- biological background Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D42 - D49. [Abstract] [PDF]

				W. S. Harris and J. H. O'Keefe Jr Invited Review: Cardioprotective Effects of {omega}-3 Fatty Acids Nutr Clin Pract, February 1, 2001; 16(1): 6 - 12. [Abstract] [PDF]